Dr. Paul A. Keown is Professor of Medicine and Director of Immunology at the University of British Columbia, with appointments in Medicine, Pathology and Laboratory Medicine. Dr. Keown graduated in Medicine from the University of Manchester, and pursued postgraduate training in England, France, and Canada. He holds research Doctorates in both Medicine and in Science from the University of Manchester, and an MBA from Simon Fraser University in British Columbia. Dr. Keown’s research focuses particularly on the immune response in transplantation and autoimmune disease, and ranges from molecular genetics to healthcare economics.
He has served as Executive Director of the British Columbia Transplant Program, Head of the UBC Division of Nephrology, president of the Canadian Transplant Society, Vice President and member of the Executive Committee of the Transplantation Society, and in numerous other national and international scientific societies and professional organizations. He is a Fellow of the Royal College of Physicians of Canada, the Royal College of Physicians of London, the Royal College of Pathologists, the Royal Society of Chemistry, the Society of Biology, the American College of Physicians, and the American Society of Nephrology. Dr. Keown is the founder and C.E.O. of Syreon Corporation, a global research corporation specializing in the use of advanced information technologies for health sciences research.
